Medical Facilities (DR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Apr, 2026Business overview
Owns two highly rated specialty surgical hospitals in the U.S., focusing on orthopedic and neurosurgical procedures.
Operates in partnership with 65 physician partners, emphasizing direct physician involvement in management.
Focuses on short-duration, non-emergency surgical, diagnostic, imaging, and pain management procedures.
Financial performance
2025 revenue and other income reached US $254.2 million, with income from operations at US $46.7 million.
2025 EBITDA was US $58.4 million, with an EBITDA margin of 23.0%.
Cash available for distribution in 2025 was C$30.3 million, with a payout ratio of 22.1%.
Maintained a strong financial position with US $43.4 million in cash and a current ratio of 1.54 as of December 31, 2025.
Shareholder returns
Repurchased 5.16 million shares for US $63.7 million in 2025 and 1.7 million shares for US $16.6 million in 2024.
Since September 2022, 11.78 million shares have been repurchased for US $119 million.
Annualized distribution per share is $0.36, with a current yield of 2.14%.
Latest events from Medical Facilities
- Strong revenue and earnings growth, major asset sales, and buybacks boosted shareholder returns.DR
Q4 202512 Mar 2026 - Revenue and EBITDA rose on strong case volumes; PPP loan forgiveness to boost Q3.DR
Q2 20242 Feb 2026 - Q3 net income up 263% and revenue up 11.2%, driven by PPP loan forgiveness and case growth.DR
Q3 202416 Jan 2026 - Net income nearly doubled in 2024, fueled by asset sales and robust capital returns.DR
Q4 202426 Dec 2025 - Revenue and EBITDA stable, net income up, and $44.3M returned to shareholders via buybacks.DR
Q1 202525 Nov 2025 - Q2 saw SFSH headwinds but strong net income growth and new $40M credit secured.DR
Q2 202523 Nov 2025 - 7.5% revenue growth, 10.2% higher EBITDA, and $5.6M in share buybacks in Q3 2025.DR
Q3 202513 Nov 2025